| European Case Law Identifier: | ECLI:EP:BA:1992:T087790.19920728 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 28 July 1992 | ||||||||
| Case number: | T 0877/90 | ||||||||
| Application number: | 81304560.6 | ||||||||
| IPC class: | C07K 15/06 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | T-cell growth factor, and a process of producing the same | ||||||||
| Applicant name: | Hooper Trading Co. N.V. | ||||||||
| Opponent name: | Biotest Pharma GmbH | ||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | State of the art - Paper distributed at a meeting - Availability to the public (yes) - Oral disclosure at the meeting (doubtful) Novelty of the product - (yes), inventive step of the product - (no) obvious desideratum Novelty and inventive step of the process - (yes) Novelty - availability to the public |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t900877eu1.html
Date retrieved: 17 May 2021